Leiomyosarcoma Clinical Trials in Philadelphia, PA

Leiomyosarcoma Clinical Trials in Philadelphia, PA

View the best 10 leiomyosarcoma medical studies in Philadelphia, Pennsylvania. Access promising new therapies by applying to a Philadelphia-based Leiomyosarcoma clinical trial.

Top rated leiomyosarcoma clinical trials in Philadelphia, Pennsylvania

Here are the top 8 medical studies for leiomyosarcoma in Philadelphia, Pennsylvania

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: April 11th, 2024

Image of Sarcoma Oncology Research Center in Santa Monica, United States.

Unesbulin +1 More

Chemotherapy

Recruiting0 awardsPhase 2 & 3
This trial will compare two different treatments for leiomyosarcoma, a type of cancer. One treatment will be the standard of care, and the other will be a new treatment that includes a drug called unesbulin. The trial will look at whether the new treatment is more effective and has fewer side effects than the standard treatment.
Image of The Ottawa Hospital - General Campus in Ottawa, Canada.

Surgery

Recruiting2 awardsPhase 3
This trialtests if chemo before surgery can help people with a certain type of cancer live longer.
Image of Mayo Clinic Arizona in Phoenix, United States.

Anlotinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 3
This trial is currently recruiting patients with alveolar soft part sarcoma only and is no longer recruiting patients with synovial sarcoma or leiomyosarcoma.
Image of Mayo Clinic Hospital in Phoenix, United States.

Doxorubicin

Anti-tumor antibiotic

Recruiting1 awardPhase 2
This trial is testing whether adding a new drug to standard treatment can help people with leiomyosarcoma that has spread to other parts of the body.
Image of Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) in Basking Ridge, United States.

Rucaparib +1 More

PARP Inhibitor

Recruiting2 awardsPhase 2
This trial is testing whether combining two drugs, rucaparib and nivolumab, may be effective in treating leiomyosarcoma (LMS), a type of cancer.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Talimogene Laherparepvec +1 More

Virus Therapy

Recruiting1 awardPhase 2
This trial is studying the side effects of talimogene laherparepvec and radiation therapy in treating patients with newly diagnosed soft tissue sarcoma.
Image of Massachusetts General Hospital in Boston, United States.

Doxorubicin +1 More

Alkylating agent

Recruiting1 awardPhase 1 & 2
This trial is studying if the combination of lurbinectedin with doxorubicin is safe and tolerable in people with soft tissue sarcoma. They will also compare the two to see which is more effective in treating leiomyosarcoma.
Image of Columbia University/Herbert Irving Cancer Center in New York, United States.

Olaparib +1 More

PARP inhibitor

Recruiting1 awardPhase 2 & 3
This trial compares using a PARP inhibitor and alkylating agent to usual treatment for advanced uterine leiomyosarcoma after chemotherapy. The combo may be more effective.

Popular filter options for leiomyosarcoma philadelphia trials

Age 65+
Phase 3
< 50 mile distance
No Placebo

Clinical Trials With No Placebo

View 12 medical studies that do not have a placebo group.

Boston, Massachusetts

Alkylating agent

Lurbinectedin + Doxorubicin for Leiomyosarcoma

Recruiting1 awardPhase 1 & 2
New York, New York
This trial is studying if the combination of lurbinectedin with doxorubicin is safe and tolerable in people with soft tissue sarcoma. They will also compare the two to see which is more effective in treating leiomyosarcoma.
Basking Ridge, New Jersey

PARP Inhibitor

Rucaparib + Nivolumab for Leiomyosarcoma

Recruiting2 awardsPhase 2
Basking Ridge, New Jersey
This trial is testing whether combining two drugs, rucaparib and nivolumab, may be effective in treating leiomyosarcoma (LMS), a type of cancer.
Orange, California

Virus Therapy

Tabelecleucel for EBV Associated Diseases

Recruiting1 awardPhase 2
New York, New York
This trial will test a new treatment for diseases caused by the Epstein-Barr virus.
New York, New York

Kinase Inhibitor

DCC-3014 + Avelumab for Sarcoma

Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug combo to see if it's safe for people with advanced sarcomas.
Ottawa, Ontario

Preoperative Chemotherapy + Surgery for Sarcoma

Recruiting2 awardsPhase 3
Philadelphia, Pennsylvania
This trialtests if chemo before surgery can help people with a certain type of cancer live longer.
Phoenix, Arizona

Anti-tumor antibiotic

L19TNF + Doxorubicin for Metastatic Leiomyosarcoma

Recruiting1 awardPhase 2
New Brunswick, New Jersey
This trial is testing whether adding a new drug to standard treatment can help people with leiomyosarcoma that has spread to other parts of the body.

View more leiomyosarcoma clinical trials philadelphia

See more medical studies focusing on leiomyosarcoma philadelphia

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top